Results 161 to 170 of about 1,533,331 (192)

Cognitive Load Across Interaction Formats in Digital Attention Assessment for Children: Within-Subject Neuroimaging and Behavioral Comparison Study. [PDF]

JMIR Serious Games
Jeong H, Cheong YJ, Ro J, Cha J, Choi J, Jung M.   +5 more
europepmc   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Human Islet. [PDF]

Cell Prolif
Zou J, Li S, Fu H, Zhang M, Hu A, Tian X, Du Y, Wei L, Chen X, Gao J, Liang R, Feng X, Li Y, Wang Y, Cai X, Sun P, Ding X, Zhang B, Liu T, Liu N, Hao J, Wang L, Zhao H, Cao J, Ma A, Zhu L, Li Q, Wei Q, Ding X, Cheng Y, Zhao T, Wang S.   +31 more
europepmc   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

Transforming Healthcare: Mozambique's Pioneering Integrative Medicine Course. [PDF]

Ann Glob Health
Hlashwayo D, Barbosa F, Martins A, Mussá T, Furvela A, Magaia T, Langa F, Madeira N, Rafael E, Munezero E, Virahsawmy N, Maculuve M, Massingue A.   +12 more
europepmc   +1 more source

In Reply to: "Response to intra-arterial chemotherapy in patients with adenoid cystic carcinoma of lacrimal gland". [PDF]

Oncologist
Costa PA, Tse DT, Benedetto P.
europepmc   +1 more source

From anthelmintic to neuro‐oncology: A systematic review of mebendazole repurposing for brain tumour therapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Mebendazole (MBZ), a benzimidazole anthelmintic with established clinical use, has emerged as a repurposing candidate for primary brain tumours due to its multimodal anticancer actions and central nervous system penetrance. This systematic review synthesizes preclinical and clinical evidence evaluating MBZ's efficacy, mechanisms of action ...
Ciara B. Blum, Milli McMenamin, Tessa Khoo, John M. Edwin, Prathibha Jose, Liam A. O’Callaghan   +5 more
wiley   +1 more source

Original vs Shoji Edition of Tanito Microhook Trabeculotomy Combined with Cataract Surgery: Comparative Clinical Outcomes. [PDF]

J Glaucoma
Shoji T, Nishida T, Tanito M.
europepmc   +1 more source

Infusion rate adjustment in enzyme replacement therapy with pabinafusp alfa for mucopolysaccharidosis II

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Enzyme replacement therapy (ERT) for mucopolysaccharidosis II (MPS II) requires long‐term, weekly intravenous infusions often lasting over 3 h each time, which can burden paediatric patients and caregivers and negatively affect their quality of life and treatment compliance.
Kimitoshi Nakamura, Norio Sakai, Hideaki Hirai, Naoko Takasao, Ryo Ibaraki, Tatsuyoshi Yamamoto, Yuji Sato   +6 more
wiley   +1 more source

In Silico Drug Design and Discovery: Big Data for Small Molecule Design-2nd Edition. [PDF]

Biomolecules
Cerchia C, Lavecchia A.
europepmc   +1 more source